Hepatitis C: Why Doctors Recommend One-Time Screening for Adults

Hepatitis C: Why Doctors Recommend One-Time Screening for Adults

Hepatitis C is a viral infection that primarily affects the liver. Left undetected, it can quietly damage liver tissue over years or decades, potentially leading to serious complications like cirrhosis or liver cancer. Because many people with hepatitis C have no obvious symptoms for a long time, one-time screening for adults has become a key public health strategy. Here's why healthcare providers encourage every adult to get tested at least once.

What Is Hepatitis C?

• Hepatitis C is caused by the hepatitis C virus (HCV).
• It spreads through contact with infected blood, most commonly via shared needles or other injection equipment.
• Acute infection may cause mild symptoms or none at all.
• Chronic (long-term) infection can lead to liver inflammation, scarring, and eventually serious liver disease.

Why One-Time Screening Matters for Adults

1. High Rate of Unrecognized Infection

   • Up to 75% of people with hepatitis C don't know they're infected.
   • Lack of symptoms in early stages means the virus can progress unnoticed.

2. Effective, Curative Treatments Available

   • New direct-acting antivirals (DAAs) can cure over 95% of cases in 8–12 weeks.
   • Early detection makes treatment simpler, less costly, and more successful.

3. Prevents Serious Health Problems

   • Treating hepatitis C before severe liver damage reduces risk of cirrhosis and liver cancer.
   • Early treatment also lowers the chance of transmitting the virus to others.

4. Public Health Recommendation

   • The U.S. Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) advise one-time hepatitis C screening for all adults aged 18–79.
   • Ongoing screening for those with continued risk factors (e.g., ongoing injection drug use).

Who Should Get Screened?

Although universal one-time screening is recommended for adults, there are groups at higher risk who may need repeat testing:

• Anyone born between 1945 and 1965 (baby boomers)
• People who have ever injected drugs, even if it was only once or many years ago
• Recipients of blood transfusions or organ transplants before 1992
• Patients on long-term hemodialysis
• Healthcare workers after a needlestick injury involving potentially infected blood
• People with HIV or certain sexually transmitted infections
• Individuals with unexplained liver enzyme elevations

How the Screening Works

1. Antibody Test (HCV Antibody)

   • A simple blood draw checks for antibodies the body makes in response to HCV.
   • A negative result usually means no past or current infection.

2. Confirmatory Test (HCV RNA/PCR)

   • If the antibody test is positive, a follow-up RNA test detects active virus in the blood.
   • This step confirms chronic infection and guides treatment decisions.

3. Optional Genotype Test

   • Determines the specific strain of HCV.
   • Helps select the most effective treatment regimen.

What to Expect During Screening

• You'll have a small blood sample taken at a clinic, doctor's office, or lab.
• Results are typically available within a few days to a week.
• If you have a positive antibody test, your provider will order the confirmatory RNA test.
• Your healthcare team will discuss next steps, including specialist referral and treatment options if needed.

Benefits of Early Detection and Treatment

• Improved Health Outcomes
  • Prevents progression to cirrhosis or liver cancer
  • Reduces fatigue, joint pain, and other subtle symptoms
• Lower Healthcare Costs
  • Treating early-stage disease is less expensive than managing advanced liver failure
• Reduced Transmission
  • Curing hepatitis C breaks the chain of infection, protecting family, partners, and communities
• Peace of Mind
  • Knowing your status frees you from uncertainty and lets you plan appropriate care

Common Myths and Facts

• Myth: "I feel fine, so I don't need screening."
  Fact: Many people with hepatitis C have no symptoms until liver damage is advanced.

• Myth: "There's no cure for hepatitis C."
  Fact: Modern treatments cure over 95% of cases with a short course of pills.

• Myth: "I don't have risk factors, so I'm safe."
  Fact: While risk factors increase chances, up to 25% of cases arise in people without clear risks.

Next Steps After Screening

• If negative, no follow-up is needed unless you engage in new risk behaviors.
• If positive for HCV RNA:
  1. Discuss antiviral treatment options with your provider.
  2. Get a liver health assessment (imaging or noninvasive tests).
  3. Follow up regularly to monitor liver function and overall health.

Take Control of Your Health

Even if you feel well, a silent hepatitis C infection can be causing damage. If you're experiencing any unusual symptoms or want to understand whether your health concerns could be related to Hepatitis C, a free AI-powered tool can help you assess your symptoms in minutes and determine whether you should schedule a screening with your doctor.

When to Speak to a Doctor

• Any unexpected fatigue, jaundice (yellowing of skin or eyes), dark urine, or abdominal pain
• Concerns about past or current risk factors (e.g., injection drug use, blood transfusions before 1992)
• Positive result on any hepatitis C screening test
• Questions about treatment options or liver health assessments

If you experience serious symptoms such as severe abdominal pain, confusion, bleeding, or signs of liver failure, seek medical attention immediately. Always talk to a healthcare professional about anything that could be life threatening or serious.

---

Getting a one-time hepatitis C screening is a simple, often covered, and potentially life-saving step. Early detection leads to better outcomes, prevents serious liver disease, and reduces the chance of spreading the virus. Speak with your doctor about scheduling a test today—and if you're uncertain about your symptoms, check out the free Hepatitis C symptom checker to better understand your health and have a more informed conversation with your healthcare provider.